eisai co ltd (4523:Tokyo Stock Exchange)
Chief Financial Officer and Representative Corporate Officer, Eisai Co., Ltd.
|Age||Total Calculated Compensation||This person is connected to 4 board members in 2 different organizations across 3 different industries.|
See Board Relationships
Mr. Hajime Shimizu serves as Chief Financial Officer and Representative Corporate Officer at Eisai Co., Ltd. Mr. Shimizu served as Deputy President and Chief Financial Officer of Japan Subsidiaries - Chief Executive Officer's special mission at Eisai Co. Ltd. Mr. Shimizu served as an Executive Vice President and President of New Markets & Asean at Eisai Co. Ltd. He served as Senior Vice President of Pharmaceuticals Business U S of Eisai Co. Ltd. Mr. Shimizu served as ...
4-6-10, KoishikawaPhone: 81 3 3817 3700
Tokyo, -- 112-8088
Board Members Memberships*
Chairman and Chief Executive Officer
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|Flemming Ornskov M.D., MBA, MPH||Managing Director, Chief Executive Officer and Director|
|Akira Kurokawa||Chief Executive Officer, President, Director, Member of Nominating Committee, Member of Executive Compensation Committee and Member of Corporate Strategy Committee|
Santen Pharmaceutical Co. Ltd.
|Eduardo Javier Sanchiz Yrazu||Chief Executive Officer, Chief Executive of Corporate Development & Finance, Executive Director, Member of Management Board and Member of Compliance Committee|
|Richard Martin Steeves Ph.D.||Group Chief Executive Officer, Member of Senior Executive Board and Executive Director|
Synergy Health plc
|823.0K GBP||Compensation as of Fiscal Year 2014.|